Sphingosine Kinase Inhibitors: A Review of Patent Literature (2006-2015)

Expert Opinion on Therapeutic Patents - United Kingdom
doi 10.1080/13543776.2016.1226282
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Nicotinic Acetylcholine Receptor Ligands, a Patent Review (2006 – 2011)

Expert Opinion on Therapeutic Patents
MedicineDrug DiscoveryPharmacology
2011English

Anti-Norovirus Therapeutics: A Patent Review (2010-2015)

Expert Opinion on Therapeutic Patents
MedicineDrug DiscoveryPharmacology
2016English

Structure–activity Relationship Studies of the Lipophilic Tail Region of Sphingosine Kinase 2 Inhibitors

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2015English

Extended-Spectrum Antiprotozoal Bumped Kinase Inhibitors: A Review

Experimental Parasitology
MedicineParasitologyInfectious DiseasesImmunology
2017English

Protein Kinase Inhibitors in Cancer Treatment: A Review

International Journal of Recent Scientific Research
2017English

Sphingosine Kinase and Sphingosine-1-Phosphate in Liver Pathobiology

Critical Reviews in Biochemistry and Molecular Biology
BiochemistryMolecular Biology
2017English

Potassium Chloride-Based Salt Substitutes: A Critical Review With a Focus on the Patent Literature

Comprehensive Reviews in Food Science and Food Safety
Food Science
2017English

Sustainability and the Financial System Review of Literature 2015

British Actuarial Journal
UncertaintyEconomicsStatisticsEconometricsProbability
2018English

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy